Daiken Medical Co

Daiken Medical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Daiken Medical Co (7775.T) as of Oct 28, 2026 is 1.28 B JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.56 B JPY — a change of -17.89% (lower).

EBITDA

1.28 BJPY

YoY

-17.89%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Daiken Medical Co is 2026 1.28 B JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Daiken Medical Co was 2025 1.56 B JPY. It decreases by -17.89% lower compared to the previous year.

The Daiken Medical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
1.30 B JPY
Jan 1, 2020
1.23 B JPY
Jan 1, 2021
995.17 M JPY
Jan 1, 2022
1.22 B JPY
Jan 1, 2023
1.11 B JPY
Jan 1, 2024
1.49 B JPY
Jan 1, 2025
1.56 B JPY
Jan 1, 2026
1.28 B JPY
The Daiken Medical Co EBITDA history
YEAREBITDAYoY
1.28 BJPY-17.89%
1.56 BJPY+4.20%
1.49 BJPY+34.63%
1.11 BJPY-8.71%
1.22 BJPY+22.09%
995.17 MJPY-19.06%
1.23 BJPY-5.41%
1.30 BJPY-16.30%
1.55 BJPY-10.67%
1.74 BJPY+1.16%
1.72 BJPY+4.56%
1.64 BJPY+15.92%
1.42 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Daiken Medical Co Stock analysis

What does Daiken Medical Co do? Daiken Medical Co., Ltd. generates revenue through the sale of anesthesia and infection control products, including the Fit Fix suction container system, Coopdech QinPot, syrinjector, balloonjector, patient control analgesia (PCA) devices, pressure infusion instruments, syringe pumps, infusion pumps, SteriKeep II, Wipell, bronchial blocker tube, and breath warm. The company targets healthcare facilities and medical institutions that require specialized equipment for anesthesia administration and infection prevention. Its product portfolio is structured into five distinct categories, each addressing specific clinical needs within operating rooms and patient care environments. Revenue streams are derived from direct sales of these medical devices to hospitals and clinics across Japan and potentially international markets. The company's suction device products, such as the Fit Fix suction container system and Coopdech QinPot, cater to procedures requiring efficient fluid management. Syrinjector-related items like the syrinjector and PCA devices support pain management and controlled drug delivery. Electric pump products, including syringe pumps and infusion pumps, are essential for precise medication administration. Medical hand washing machines like SteriKeep II and Wipell are designed for infection control protocols, while other products such as bronchial blocker tubes and breath warm devices serve niche surgical applications. All products are sold directly to healthcare providers without third-party intermediaries. Daiken Medical Co., Ltd. focuses on delivering specialized medical equipment that addresses critical needs in anesthesia and infection control. Its product groups are tailored to meet the operational requirements of hospitals and clinics, ensuring compliance with medical standards. The company’s revenue model relies on consistent demand for these high-precision devices, with no indication of additional services or subscription-based offerings in its business description. Daiken Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Daiken Medical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Daiken Medical Co is 1.28 B JPY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Daiken Medical Co changed from 1.56 B JPY to 1.28 B JPY, representing a -17.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Daiken Medical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Daiken Medical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Daiken Medical Co

All Key Metrics — Daiken Medical Co